The largest database of trusted experimental protocols

Dmem f12 medium

Manufactured by Merck Group
Sourced in United States, Germany, Poland, Macao, United Kingdom, Sao Tome and Principe, Japan, Italy, Switzerland, India

DMEM/F12 medium is a widely used cell culture medium formulation developed by Dulbecco and Freeman. It is a basal medium that provides a balanced salt solution, amino acids, vitamins, and other nutrients required for the growth and maintenance of a variety of cell types.

Automatically generated - may contain errors

260 protocols using dmem f12 medium

1

Isolation and BMP Stimulation of Endothelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The area vitellina of yolk sacs was dissected from the area vasculosa as previously described.5 The intact cell sheets of the area vitellina were disrupted by repeated pipetting until a homogenous cell suspension was obtained. Cells were resuspended in fresh DMEM‐F12 medium (Sigma) supplemented with 10% FCS, 2 mM l‐glutamine, 0.1 mg/mL streptomycin, and 100 units/mL penicillin, plated at high density on sterile 6‐well cell culture dishes and grown for 48 hours in complete DMEM‐F12 medium at 37°C and 5% CO2. For the detection of SMAD5 phosphorylation, EECs were washed 2× in PBS, starved for 2 hours in Opti‐MEM reduced serum medium followed by the incubation of the cells with recombinant mouse BMP4 or BMP7 proteins (R&D systems) at the indicated concentrations for 40 minutes. For the analysis of gene expression in BMP‐stimulated EECs, freshly isolated EECs were cultured for 48 hours in complete DMEM‐F12 medium containing 200 ng/mL recombinant BMP4 or BMP7 proteins as indicated in the figure legends (medium and BMPs were replaced after 24 hours).
+ Open protocol
+ Expand
2

Isolation and Stimulation of OA Chondrocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human samples including cartilage and synovial fluid samples were obtained from OA patients undergoing total knee arthroplasty. Tissues and synovial fluids were obtained from 4 OA patients including 1 man and 3 women with mean age of 74 years (59-83 years) who underwent total knee arthroplasty. Obtained cartilage were fixed by 10% formalin for 24 h, decalcified by EDTA for 1 week at 4°C and then embedded frontally in paraffin. To isolate OA chondrocytes, cartilage was cut into small pieces and digested with 0.15% collagenase II solution (Gibco) in DMEM/F12 medium (Sigma) overnight at 37°C-water bath with shaking (Oseni et al., 2013 (link)). Cells were suspended in DMEM/F12 medium supplemented with 10% heat-inactivated fetal bovine serum (FBS; Sigma-Aldrich), 25 mg/L penicillin/streptomycin and cultured in a 37°C humidified atmosphere containing 5% CO2. After 5 days, chondrocytes were detached using 1% trypsin-EDTA solution (Wako), washed by PBS, seeded at 1X105 and stimulated with recombinant human IL-1β or TNF-α (Peprotech) for 24 h. Synovial fluids of OA knee samples were centrifuged at 2000 x g at 4°C for 10 min to remove cells/debris and preserved at -80°C until further analysis.
+ Open protocol
+ Expand
3

LUHMES Cell Proliferation and Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation, LUHMES cells (15 (link)) were kept on flasks (Nunc, Thermo Fisher Scientific, Waltham, MA, USA), coated with poly-L-ornithine (0.1 mg/ml; 4°C, overnight; Sigma-Aldrich, St. Louis, MO, USA) in a DMEM/F12 medium (Sigma-Aldrich, St. Louis, MO, USA) with 1% N2-supplement (Thermo Fisher Scientific) and a 0.04 μg/ml basic fibroblast growth factor (bFGF, PeproTech, Rocky Hill, CT, USA). For differentiation, the cells were seeded in a differentiation medium at a density of 100,000 cells per cm2 on cell culture dishes coated with poly-L-ornithine (0.1 mg/ml; 4°C, overnight; Sigma-Aldrich), followed by coating with fibronection (5 μg/ml, 37°C, overnight; Sigma-Aldrich). The differentiation medium consisted of a DMEM/F12 medium with 1% N2-supplement, 1-μg/ml tetracycline (Sigma-Aldrich), 0.49-μg/ml dibutyryl cyclic adenosine monophosphate, and a 2-ng/ml glial cell-derived neurotrophic factor (GDNF, R&D Systems, Minneapolis, MN, USA).
+ Open protocol
+ Expand
4

Differentiation and Maintenance of LUHMES Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For proliferation, LUHMES cells were kept in flasks coated with poly-L-ornithine (0.1 mg/mL; 4 °C, overnight; Sigma-Aldrich) in a DMEM/F12 medium (Sigma-Aldrich) with 1% N2-supplement (Thermo Fisher Scientific, Cat#: 17502048), 2 mM L-Glutamine (Thermo Fisher Scientific), and a 0.04 μg/mL human basic fibroblast growth factor (bFGF, Gibco, Cat#: 13256-029). For differentiation, the cells were seeded in a differentiation medium at a density of 100,000 cells per cm2 in the cell culture dishes coated with poly-L-ornithine (50 μg/mL; 4 °C, overnight; Sigma-Aldrich), followed by coating with human fibronectin (1 μg/mL, 37 °C, overnight; Sigma-Aldrich). The differentiation medium consisted of a DMEM/F12 medium with 1% N2-supplement, 1 μg/mL tetracycline (Sigma-Aldrich), 1 mM dibutyryl cAMP (Sigma-Aldrich), and a 2 ng/mL glial cell-derived neurotrophic factor (GDNF) (Sigma-Aldrich, Cat#: G1777). To handle LUHMES spheroid culture, between 1000 and 3000 cells were seeded into ultra-low attachment, U-shaped, 96-well plate (CellCarrier Spheroid ULA 96-well Microplates, Perkin Elmer, Cat#: 6055330) with 100 μL of LUHMES proliferating medium.
+ Open protocol
+ Expand
5

Culturing Breast Cancer and Mammary Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The MDA-MB-231 (HTB-26) and MCF-7 breast cancer cell lines (American Type Culture Collection (ATCC), Manassas, VA, USA) were cultured in RPMI 1640 medium (Lonza, Basel, Switzerland). The cancer cell media were supplemented with 10% heat-inactivated fetal bovine serum (Biowest, Nuaillé, France) and 1.0% penicillin/streptomycin (Lonza, Basel, Switzerland). Conversely, the normal epithelial MCF-12F (CRL-10783) mammary gland cells (ATCC, Manassas, VA, USA) were grown in DMEM/F-12 medium (Sigma-Aldrich, St Louis, MO, USA). The DMEM/F-12 medium was enriched with 7.0% fetal horse serum, 10 µg/mL human insulin, 20 ng/mL epidermal growth factor, 500 ng/mL hydrocortisone, 100 mg/mL cholera toxin, and 1.0% penicillin/streptomycin, all obtained from Sigma-Aldrich, St Louis, MO, USA.
+ Open protocol
+ Expand
6

Dissociation of Ipsilateral DRG Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
L46 DRG neurons from the ipsilateral side of the operation were dissociated using enzyme digestion as previously described (Zhang et al., 2017 (link)). The drug-intervention group DRGs were treated with 17β-estradiol and Cltx. Briefly, the excised ganglia were freed from their connective tissue sheaths and cut into pieces with a pair of sclerotic scissors in DMEM/F12 medium (GIBCO; Thermo Fisher Scientific, Waltham, MA, United States) under low temperature on ice. The fragments were transferred into 5 mL of DMEM/F12 medium containing trypsin (0.4 mg/mL, Sigma) and collagenase (type IA, 0.6 mg/mL, Sigma) and incubated for 5 min at 37°C. The ganglia were then gently triturated using fine fire-polished Pasteur pipettes. The suspension was dissociated in DMEM/F12 medium, supplemented with 10% fetal bovine serum, and DRG neurons were plated on glass cover slips coated with Poly-L-Lysine (Sigma). Cells were maintained in a humidified atmosphere (5% CO2, 37°C) and used for electrophysiological recordings 6–24 h after plating.
+ Open protocol
+ Expand
7

Xenograft and Sphere Culture of Murine and Human Glioma Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mice All mouse strains were housed in a barrier facility under protocols approved by the Institutional Animal Care and Use Committee of Weill Cornell Medicine. Rag -/-mice were purchased from the Jackson Laboratories (JAX stock #002216), bred at the institution's animal facility, and used for graft or xenograft between 8 and 12 weeks of age.
Cell culture Sphere culture of iEIP cells was established and maintained in serum-free DMEM/F12 medium (Sigma), containing ITS (Invitrogen), epidermal growth factor (EGF) (20 ng/ml, Peprotech), and basic fibroblast growth factor (bFGF) (20 ng/ml; Peprotech) as previously described (60) . The human glioma initiating cells (GS7-11, GS8-11, GSC280) were maintained in serum-free DMEM/F12 medium (Sigma), containing B27 (Invitrogen), 20 ng/ml EGF, and 20 ng/ml bFGF.
+ Open protocol
+ Expand
8

Establishing and Maintaining iEIP Cell Spheres

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sphere culture of iEIP cells was established and maintained in serum-free DMEM/F12 medium (Sigma), containing ITS (Invitrogen), EGF (20 ng/mL, Peprotech), and basic fibroblast growth factor (bFGF; 20 ng/mL; Peprotech) as previously described (17) . The human glioma initiating cells (GS7-11, GSC280) were provided by Dr. Erik Sulman (NYU Langone Health, New York, NY) and maintained in serum-free DMEM/F12 medium (Sigma), containing B27 (Invitrogen), 20 ng/mL EGF, and 20 ng/mL bFGF. Low passage cultures were frozen down and used within 2-3 passages when thawed, for all experiments. All cultures were routinely subject to Mycoplasma testing and authentication.
+ Open protocol
+ Expand
9

Establishing Human Glioblastoma Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The human glioblastoma cell lines A172 and T98G were obtained from ATCC. A172 and T98G cells were cultured in Dulbecco's modified Eagle's medium (DMEM)/F-12 medium (Sigma Aldrich, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (Nichirei) and 1% penicillin/streptomycin/amphotericin (Nacalai Tesque, Kyoto, Japan).
To establish human GSCs, samples from human GBMs were dissociated with the Papain Dissociation System (Worthington Biochemical Corporation, Lakewood, NJ, USA). After filtration, dissociated cells were cultured in serum-free medium with growth factors as previously described (Anai et al., 2014 (link); Singh et al., 2004 (link)). All cells were incubated at 37 °C in an atmosphere containing 5% CO2. To confirm their tumor-forming potential, 1 × 105 GSCs were injected into the brains of 8-week-old female ICR-nu mice (Crlj:CD1-Foxn1nu; Charles River Japan) after anesthesia. Four weeks later, xenograft tumors had formed in the brain. Pathologically, the tumors showed high cellularity and necrosis similar to that of the original tumor (Fig. 3A and B).
+ Open protocol
+ Expand
10

Culturing Pancreatic Cancer and Stellate Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
All pancreatic cells were maintained free of antibiotics in DMEM:F12 medium (Sigma, Gillingham, UK) supplemented with 10% foetal bovine serum (FBS; Gibco, Loughborough, UK) at 37 °C in 5% CO2. Human Miapaca2 and Panc‐1 pancreatic cancer cell lines were a kind gift from Professor Hemant Kocher (Barts Cancer Institute, London, UK). Mouse pancreatic cancer cell lines R254 and DT6066 were derived from KPF and KPC pancreatic tumours, respectively [8 (link), 11 (link)], and were a kind gift from Professor Kairbaan Hodivala‐Dilke (Barts Cancer Institute). PS1 stellate cells were a kind gift from Professor Hemant Kocher (Barts Cancer Institute). Mouse PSCs were isolated from wildtype C57BL/6 mice as described [8 (link)]. The 1089 myoepithelial cell line, a kind gift from Professor Louise Jones (Barts Cancer Institute), was maintained free of antibiotics in Ham's F12 medium (Gibco), supplemented with 10% FBS, 0.5 μg/ml hydrocortisone (Sigma), 10 ng/ml Epidermal Growth Factor (Sigma), and 5 μg/ml Insulin (Sigma).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!